Table 2.
Performance criteria of self-reported ART use by age and sex in HAALSI
| Population | PPV (95% CI) | NPV (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) |
|---|---|---|---|---|
| Overall | 96.1 (94.4 – 97.8) | 51.9 (47.8 – 56.1) | 64.4 (60.9 – 67.9) | 93.7 (90.9 – 96.4) |
| Male | 94.8 (90.9 – 97.2) | 50.2 (43.7 – 56.7) | 64.9 (59.6 – 69.9) | 90.9 (84.4 – 95.0) |
| Female | 97.2 (94.2 – 98.8) | 53.3 (47.5 – 59.0) | 64.0 (59.0 – 68.7) | 95.8 (91.3 – 98.1) |
| Age 40–49 | 91.7 (85.3 – 95.6) | 59.3 (51.5 – 66.6) | 63.5 (56.2 – 70.2) | 93.2 (82.9 – 94.8) |
| Age 50–59 | 96.9 (93.2 – 98.8) | 49.2 (41.9 – 56.6) | 66.9 (60.1 – 72.2) | 93.9 (86.6 – 97.5) |
| Age 60–69 | 98.3 (93.3 – 99.7) | 45.6 (36.9 – 54.7) | 62.5 (55.0 – 69.4) | 96.7 (87.5 – 99.4) |
| Age 70+ | 100.0 (84.5 – 100.0) | 40.5 (29.5 – 52.6) | 38.0 (27.0 – 50.3) | 100.0 (85.8 – 100.0) |